Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aveanna Healthcare Holdings (AVAH) Interest Expenses (2020 - 2026)

Aveanna Healthcare Holdings (AVAH) has disclosed Interest Expenses for 6 consecutive years, with $35.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Interest Expenses fell 10.49% year-over-year to $35.1 million, compared with a TTM value of -$5.5 million through Sep 2025, down 102.8%, and an annual FY2024 reading of $5.5 million, down 96.41% over the prior year.
  • Interest Expenses was $35.1 million for Q3 2025 at Aveanna Healthcare Holdings, down from $36.0 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $79.5 million in Q4 2023 and bottomed at -$113.0 million in Q4 2024.
  • Average Interest Expenses over 5 years is $24.3 million, with a median of $36.0 million recorded in 2023.
  • The sharpest move saw Interest Expenses skyrocketed 964.95% in 2022, then crashed 242.14% in 2024.
  • Year by year, Interest Expenses stood at $12.1 million in 2021, then surged by 135.11% to $28.5 million in 2022, then soared by 179.32% to $79.5 million in 2023, then plummeted by 242.14% to -$113.0 million in 2024, then skyrocketed by 131.08% to $35.1 million in 2025.
  • Business Quant data shows Interest Expenses for AVAH at $35.1 million in Q3 2025, $36.0 million in Q2 2025, and $36.3 million in Q1 2025.